(APLE) Apple Hospitality REIT - Overview
Stock: Hotels, Guest Rooms, REIT
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 7.93% |
| Yield on Cost 5y | 9.33% |
| Yield CAGR 5y | 121.34% |
| Payout Consistency | 79.3% |
| Payout Ratio | 53.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 24.1% |
| Relative Tail Risk | -7.25% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.62 |
| Alpha | -30.97 |
| Character TTM | |
|---|---|
| Beta | 1.047 |
| Beta Downside | 0.952 |
| Drawdowns 3y | |
|---|---|
| Max DD | 32.95% |
| CAGR/Max DD | -0.13 |
Description: APLE Apple Hospitality REIT January 12, 2026
Apple Hospitality REIT, Inc. (NYSE: APLE) is a U.S.-based REIT that owns and operates a diversified portfolio of upscale, rooms-focused hotels. The company’s assets comprise roughly 220 hotels and 29,700 guest rooms across 85 markets in 37 states plus the District of Columbia, with brand exposure dominated by Marriott (≈96 hotels) and Hilton (≈118 hotels), plus a handful of Hyatt and independent properties.
As of the latest quarterly filing (Q3 2024), the REIT reported an aggregate occupancy rate of about 73% and an average daily rate (ADR) of $128, yielding a RevPAR near $93-both metrics trailing the pre-pandemic averages but tracking above the broader hotel industry’s 68% occupancy benchmark.
Key economic drivers for APLE include discretionary consumer spending, business-travel demand, and the prevailing interest-rate environment, which influences both financing costs and the attractiveness of REIT yields relative to fixed-income alternatives. A 100-basis-point rise in the 10-year Treasury rate typically compresses REIT price-to-FFO multiples by roughly 5% in this sector.
Given the current macro backdrop, APLE’s exposure to high-margin branded contracts and its geographic diversification provide a partial hedge against localized market slowdowns, but the REIT remains sensitive to any prolonged weakness in travel demand.
For a deeper dive into APLE’s valuation metrics and scenario analysis, you might find the tools on ValueRay worth exploring.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 175.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -0.35 > 1.0 |
| NWC/Revenue: 4.54% < 20% (prev -8.75%; Δ 13.29% < -1%) |
| CFO/TA 0.08 > 3% & CFO 379.6m > Net Income 175.6m |
| Net Debt (1.57b) to EBITDA (428.7m): 3.66 < 3 |
| Current Ratio: 1.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (237.1m) vs 12m ago -1.43% < -2% |
| Gross Margin: 44.64% > 18% (prev 0.36%; Δ 4429 % > 0.5%) |
| Asset Turnover: 28.56% > 50% (prev 28.10%; Δ 0.47% > 0%) |
| Interest Coverage Ratio: 2.90 > 6 (EBITDA TTM 428.7m / Interest Expense TTM 81.6m) |
Altman Z'' 1.32
| A: 0.01 (Total Current Assets 168.8m - Total Current Liabilities 104.4m) / Total Assets 4.91b |
| B: -0.31 (Retained Earnings -1.55b / Total Assets 4.91b) |
| C: 0.05 (EBIT TTM 236.7m / Avg Total Assets 4.97b) |
| D: 1.85 (Book Value of Equity 3.19b / Total Liabilities 1.72b) |
| Altman-Z'' Score: 1.32 = BB |
What is the price of APLE shares?
Over the past week, the price has changed by +4.47%, over one month by -0.38%, over three months by +10.30% and over the past year by -16.99%.
Is APLE a buy, sell or hold?
- StrongBuy: 2
- Buy: 1
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the APLE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13.1 | 8.1% |
| Analysts Target Price | 13.1 | 8.1% |
| ValueRay Target Price | 14.2 | 17.1% |
APLE Fundamental Data Overview February 05, 2026
P/E Forward = 15.9744
P/S = 1.9741
P/B = 0.8766
Revenue TTM = 1.42b USD
EBIT TTM = 236.7m USD
EBITDA TTM = 428.7m USD
Long Term Debt = 1.51b USD (from longTermDebt, last quarter)
Short Term Debt = 31.0m USD (from shortTermDebt, last quarter)
Debt = 1.62b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.57b USD (from netDebt column, last quarter)
Enterprise Value = 4.37b USD (2.80b + Debt 1.62b - CCE 50.3m)
Interest Coverage Ratio = 2.90 (Ebit TTM 236.7m / Interest Expense TTM 81.6m)
EV/FCF = 12.18x (Enterprise Value 4.37b / FCF TTM 358.8m)
FCF Yield = 8.21% (FCF TTM 358.8m / Enterprise Value 4.37b)
FCF Margin = 25.29% (FCF TTM 358.8m / Revenue TTM 1.42b)
Net Margin = 12.37% (Net Income TTM 175.6m / Revenue TTM 1.42b)
Gross Margin = 44.64% ((Revenue TTM 1.42b - Cost of Revenue TTM 785.5m) / Revenue TTM)
Gross Margin QoQ = 74.87% (prev 36.67%)
Tobins Q-Ratio = 0.89 (Enterprise Value 4.37b / Total Assets 4.91b)
Interest Expense / Debt = 1.32% (Interest Expense 21.4m / Debt 1.62b)
Taxrate = 0.47% (242.0k / 51.1m)
NOPAT = 235.6m (EBIT 236.7m * (1 - 0.47%))
Current Ratio = 1.62 (Total Current Assets 168.8m / Total Current Liabilities 104.4m)
Debt / Equity = 0.51 (Debt 1.62b / totalStockholderEquity, last quarter 3.19b)
Debt / EBITDA = 3.66 (Net Debt 1.57b / EBITDA 428.7m)
Debt / FCF = 4.37 (Net Debt 1.57b / FCF TTM 358.8m)
Total Stockholder Equity = 3.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.53% (Net Income 175.6m / Total Assets 4.91b)
RoE = 5.46% (Net Income TTM 175.6m / Total Stockholder Equity 3.22b)
RoCE = 5.01% (EBIT 236.7m / Capital Employed (Equity 3.22b + L.T.Debt 1.51b))
RoIC = 4.98% (NOPAT 235.6m / Invested Capital 4.73b)
WACC = 6.67% (E(2.80b)/V(4.42b) * Re(9.77%) + D(1.62b)/V(4.42b) * Rd(1.32%) * (1-Tc(0.00)))
Discount Rate = 9.77% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.53%
[DCF Debug] Terminal Value 84.28% ; FCFF base≈369.0m ; Y1≈406.8m ; Y5≈523.4m
Fair Price DCF = 45.20 (EV 12.26b - Net Debt 1.57b = Equity 10.69b / Shares 236.6m; r=6.67% [WACC]; 5y FCF grow 11.76% → 2.90% )
EPS Correlation: -17.68 | EPS CAGR: -33.89% | SUE: -3.03 | # QB: 0
Revenue Correlation: 69.84 | Revenue CAGR: 11.26% | SUE: 0.89 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.13 | Chg30d=+0.010 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=0.74 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=-12.2% | Growth Revenue=+1.7%